T0	Interventions 0 11	Eltrombopag
T1	Interventions 121 132	Eltrombopag
T2	Interventions 139 175	oral thrombopoietin receptor agonist
T3	Interventions 262 288	eltrombopag versus placebo
T4	Interventions 409 427	placebo-controlled
T5	Interventions 671 675	plus
T6	Interventions 679 713	mg eltrombopag or matching placebo
T7	Interventions 1314 1352	response to eltrombopag versus placebo
T8	Interventions 1618 1647	(135 eltrombopag, 62 placebo)
T9	Interventions 1668 1686	in the eltrombopag
T10	Interventions 1850 1868	in the eltrombopag
T11	Interventions 1895 1909	in the placebo
T12	Interventions 2021 2042	receiving eltrombopag
T13	Interventions 2099 2108	receiving
T14	Interventions 2146 2167	receiving eltrombopag
T15	Interventions 2224 2233	receiving
T16	Interventions 2264 2294	patients receiving eltrombopag
T17	Interventions 2343 2351	patients
T18	Interventions 2362 2363	.
T19	Interventions 2364 2393	Nine (7%) eltrombopag-treated
T20	Interventions 2411 2422	(3%) in the
T21	Interventions 2499 2532	and five (4%) eltrombopag-treated
T22	Interventions 2551 2560	allocated
T23	Interventions 2617 2632	patients taking
T24	Interventions 2702 2726	treated with eltrombopag
T25	Interventions 2728 2754	INTERPRETATION Eltrombopag
T26	Interventions 2989 3016	associated with eltrombopag